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ABSTRACT 
~S-cysteine injected adjacent to the supraoptic nucleus (SON) of the rat is rapidly 
incorporated into proteins. These 35S-cysteine-labeled proteins in the SON (1-24 
h after injection) were separated by polyacrylamide gel electrophoresis, and the 
distribution of radioactive proteins on the gels was analyzed. 1 h after injection, 
about 73%  of the radioactivity appeared in two peaks  (both about 20,000  mol 
wt). With time, these peaks (putative precursors of neurophysin) decreased, as a 
12,000 mol wt peak (containing two distinct neurophysins) increased in radioac- 
tivity. Both  the  20,000-  and  12,000-mol  wt proteins  are  transported  into  the 
axonal (median eminence) and nerve terminal (posterior pituitary) regions of the 
rat  hypothalamo-neurohypophysial system. Conversion  of the  larger  precursor 
protein to the smaller neurophysin appears to occur, in large part, intra-axonally 
during axonal transport.  Six distinct aSS-cysteine-labeled peptides (<  2500  mol 
wt), in addition to arginine vasopressin and oxytocin, are also synthesized in the 
SON and transported to the posterior pituitary where they are released together 
with labeled neurophysin by potassium depolarization in the presence of extracel- 
lular calcium. These data provide support for the hypothesis that the neurohypo- 
physial peptides (vasopressin and oxytocin) and neurophysins are derived from 
the post-translational cleavage of protein precursors synthesized in the SON, and 
that the conversion process can occur in the neurosecretory granule during axonal 
transport. 
The question whether neuronal peptides are syn- 
thesized by ribosomal mechanisms as protein pre- 
cursors and then transformed to biologically active 
peptides  by  post-translational  cleavage  mecha- 
nisms, similar to those for insulin (47), or by direct 
enzymic  (synthetase)  mechanisms  has  received 
considerable  attention in recent years (38).  The 
answer  to this  question  has several  implications 
with regard to the cell biology of "peptidergic" 
neurons, i.e., neurons which synthesize and store 
specific peptides  for release  as intercellular  mes- 
sengers (3, 13, 30). Since ribosomes appear to be 
restricted  to  the  neuron  perikaryon  (21),  ribo- 
somal  mechanisms  of peptide  biosynthesis  and 
their regulation would necessarily have to occur at 
this  site in  the neuron. In contrast, an enzymic 
mechanism  of  biosynthesis  would  allow  these 
processes to occur in any part of the neuron (e.g., 
the axon terminal), analogous to the synthesis of 
conventional  neurotransmitters  (e.g.,  acetylcho- 
line,  gamma aminobutyric  acid,  catecholamines, 
etc.). 
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pothalamo-neurohypophysiai system represent ex- 
cellent models for such studies. The  neurohypo- 
physial peptides (oxytocin and  vasopressin) and 
proteins (neurophysins)  are  synthesized by  neu- 
rons in the supraoptic nucleus  (SON)  and  para- 
ventricular  nucleus  (PVN)  of the  hypothalamus 
and subsequently transported intra-axonally to the 
posterior pituitary (neurohypophysis) where they 
are stored in nerve  terminals for release (2,  15, 
22). As a  result of their extensive investigations, 
Sachs and his colleagues (44) have hypothesized 
that vasopressin and neurophysin are derived from 
a common precursor protein which is synthesized 
by ribosomal mechanisms. The evidence in  sup- 
port of this hypothesis is as follows: (a) the synthe- 
sis of vasopressin occurs  only at  the  site of the 
neuronal perikarya in the hypothalamus. The neu- 
rohypophysis, containing the axons and terminals 
of these same neurons, is incapable of vasopressin 
synthesis (40, 42). (b) In vivo and in vitro experi- 
ments  on  the  incorporation  of ~S-cysteine into 
vasopressin  showed  that  labeled vasopressin  ap- 
peared only after a significant time lag (>1.5 h in 
the dog). Application of a protein synthesis inhibi- 
tor,  puromycin,  during  the  pulse-label  period 
completely inhibits the  incorporation of ~S-cys- 
teine into vasopressin, whereas if the puromycin is 
applied after the pulse (but before the appearance 
of labeled vasopressin) the incorporation of label 
into  the  peptide  is  not  inhibited  (42,  44,  50). 
Sachs and Takabatake (42) concluded from these 
findings that puromycin inhibited the synthesis of 
the  precursor,  but  that  once  the  precursor  was 
synthesized the inhibitor did not affect the cleav- 
age of the precursor to vasopressin. (c) Neurophy- 
sin and vasopressin appear to be synthesized with 
similar kinetics (43), and inhibition of neurophy- 
sin synthesis by incubation in the presence of ana- 
logues of amino  acids found  in  neurophysin but 
not vasopressin also inhibited the synthesis of va- 
sopressin  (44).  These  data indicated a  common 
precursor for both neurophysin and vasopressin. 
(d) Consistent with this hypothesis are the recent 
findings that rats with genetic defects in vasopres- 
sin synthesis, i.e., the Brattleboro strain, are also 
deficient in specifically the vasopressin-associated 
neurophysin (37, 52). (e) Various physical-chemi- 
cal  properties  of  neurophysin  suggest  that  this 
protein is not in its originally synthesized form (8). 
Although  considerable  evidence  for  the  exis- 
tence of a precursor of neurophysin and vasopres- 
sin has been available, efforts to isolate and char- 
acterize this postulated precursor in biosynthetic 
experiments have  been  unsuccessful.  In this pa- 
per,  we  present  evidence  for the  existence of a 
protein  precursor  to  neurophysin  in  the  rat  hy- 
pothalamo-neurohypophysiai system, its tentative 
identification as a protein of 20,000  mol wt, and 
evidence  for  its  post-translational  modification 
during axonal transport. With the use of the bio- 
synthesis-axonal transport paradigm described in 
this paper, we have detected several cysteine-con- 
taining peptides, other than vasopressin and oxy- 
tocin, which appear to be transported to the poste- 
rior pituitary for release. A preliminary account of 
this work has been published (14). 
MATERIALS  AND  METHODS 
Animals and Operative Procedures 
Rats of the Osborne-Mendel  strain were used in these 
experiments. The animals were anaesthetized with ether, 
and  their heads were fixed in a stereotaxic  instrument 
(5 ~  nose  down).  A  flap of skull bone was removed, 
exposing  the  brain,  and  two  31-gauge,  stainless steel 
needles were positioned 7 mm rostral to the interauricu- 
lar line, 2.5 mm on each side of the midline. The needles 
were lowered 8.6 mm beneath the dural surface, and 1 
/~1 of a solution containing 10 #,Ci of ~S-l-cystine  (50 Ci/ 
retool, New England  Nuclear,  Boston,  Mass.) in 0.9% 
NaCI  and  10  mM  dithiothreitol was injected through 
each needle over a period of 10 rain. After the injection, 
the needles were left in position for 10 rain, and were 
then removed from the brain. Histological examination 
of the brains showed that the tips of the needles had been 
just above and lateral to the supraoptic  nuclei (SON). 
The scalp was dosed with wound clips, and the animals 
awoke  10 rain postoperatively.  At various times post- 
injection, the animals were  sacrificed by decapitation, 
and their brains and pituitaries  were  quickly removed 
and frozen on dry ice. Serial frontal sections (300/~m  in 
thickness) of the brain were cut in a cryostat at -9~ 
The  SON  where  oxytocin  and  vasopressin  containing 
neuronal perikarya are found (49), and the median emi- 
nence (ME) through which axons from the SON neurons 
pass,  were dissected by the Palkovitz punch  technique 
(35).  The  posterior pituitary, where  the axons  of the 
hypothalamo-neurohypophysial  system  terminate, was 
also studied. These tissue samples were homogenized in 
0.1 N HCI in order to destroy degradative enzymes (11), 
and the homogenates  were stored at -70~ 
Polyacrylamide Gel Electrophoresis 
of Labeled Proteins 
Four  types  of  polyacrylamide  gel  electrophoresis 
(PAGE) were used to separate ~S-labeled proteins from 
the  isolated tissues:  acid-urea gels,  basic gels  (with  a 
running  pH of 9.5), electrophoresis  in the presence of 
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(IEF) gels. Two methods were used to prepare the tissue 
samples for electrophoresis. (a) The tissues were directly 
homogenized in a sample buffer (see below) appropriate 
for the gel system to be used, and the homogenate was 
centrifuged  at  12,000  gmax. The  supernate  was  then 
applied directly to the gel for electrophoresis. (b) The 
tissues which had been homogenized in 0.1 M HCI were 
treated with 10%  TCA,  and the precipitated proteins 
were separated from the TCA-soluble proteins by cen- 
trifugation. Both the TCA-precipitable and-soluble frac- 
tions were washed extensively with ether to remove the 
TCA and stored at -70"C until use. The TCA-precipita- 
ble fraction was solubilized by the specific sample buffer 
and subjected to electrophoresis. The TCA-soluble pep- 
tides were analyzed as will be described later. 
The acid-urea polyacrylamide gels were prepared as 
described elsewhere (24), except that the separating gel 
also contained 0.1%  Triton X-100.  Electrophoresis in 
the system is toward the cathode, and the running pH of 
the gel is 2.7. The sample buffer contained 8 M urea, 1% 
Triton X-100, and 0.9 M  acetic acid. SDS gel electro- 
phoresis was done with the buffer system described by 
Neville (29). The running pH of this system is 9.5, and 
the sample buffer contained 1% SDS, and 2% /3-mer- 
captoethanol made up in the upper gel buffer (29). This 
same gel system, in the absence of SDS and/3-mercapto- 
ethanol, was used to separate proteins on the basis of 
their charge and size, and is referred to as the "pH 9.5 
gel" in the text. IEF in polyacrylamide gels was done 
according to the  method described by O'Farrell  (34). 
The sample buffer used with this gel system contained 8 
M urea, 1% Triton X-100, and 2% ampholytes (pH 3- 
10), and the sample was loaded at the anode end of the 
gel. Conventional disc gels were used when the radioac- 
tive  patterns on  the  gels  were  determined by  slicing 
techniques, and slab gels were used for radioautographic 
analysis.  After  electrophoresis,  the  gels  were  stained 
with  Coomassie  Blue  and  destained  by  conventional 
techniques. Several marker proteins were used to stand- 
ardize  each gel  run. The  marker proteins were  either 
added to the sample buffer containing the labeled pro- 
teins (providing an internal standard for the gel) or co-run 
during the same gel electrophoresis run on  a  separate 
gel.  The marker proteins used for acid-urea gels were 
bovine serum albumin, cytochrome c, and bovine neuro- 
physin  I  and  II  (obtained  as  a  gift from  Dr.  E.  Di- 
liberto).  The  same  marker  proteins,  except  for  eyto- 
chrome c,  were  used for the  pH  9.5  gel,  and bovine 
serum albumin (68,000 mol wt), ovalbumin (43,000 mol 
wt), carbonic anhydrase (29,000 mol wt), cytochrome c 
(12,000  tool wt), and insulin a  and /3 subunits (2,500 
and 3,500 mol wt) were used in SDS gel electrophoresis. 
In some experiments, the labeled proteins were elec- 
trophoresed on acid-urea gels, and after electrophoresis, 
the gels were sliced longitudinally into two halves. One 
half was sliced and counted for its radioactive profile, 
and  the  other  half was  frozen  at  -70~  When  the 
migration proteins on the gels of the labeled proteins 
were determined, the slices containing the labeled pro- 
teins of interest were sliced out of the frozen gel, frag- 
mented, and eluted in either SDS or IEF sample buffer. 
The sample buffer and gel fragments were then applied 
to either SDS or IEF gels for electrophoresis. 
Analysis of TCA-Soluble Peptides 
The TCA-soluble fractions were chromatographed on 
Sephadex  G-25  columns  (0.9  x  30  cm,  Pharmacia- 
Uppsala, Sweden) with 5% acetic acid as the eluant. The 
TCA-soluble fractions were lyophilized, dissolved in 0.2 
ml of 5 % acetic acid and applied to the column without 
disturbing the gel, and eluted. Flow rates were about 40 
ml/h, and blue dextran, arglnine vasopressin, and ribo- 
flavin were used as markers on the G-25 column. Ali- 
quots from the resulting fractions were counted for their 
radioactivity, and the radioactive fractions preceding the 
riboflavin fraction were pooled and lyophilized. The ly- 
ophilized peptides were dissolved in a small volume of 
5% acetic acid, and spotted on cellulose (500/.tm thick) 
thin-layer chromatography (TLC) plates (Analtech, Inc., 
Newark,  Del.), for two-dimensional TLC. The solvent 
used for the first dimension (solvent 1) contained bu- 
tanol:HzO:pyridine in the  ratio  1:1:1,  while solvent 2 
contained butanol:HzO:acetic acid:pyridine in the ratios 
of 3:3:1:3. The antioxidant thiodiglycol (0.1% vol/vol) 
was also added to both solvents. Arginine vasopressin 
and oxytocin were added to each sample and detected on 
each plate at the end of the chromatographic separation 
by fluorescamine treatment of the plate (17). The addi- 
tion of these  peptide  markers served as  internal stan- 
dards for each run, and also provided information as to 
the position of these peptides on the plate. The plates 
were radioautographed as described below. 
Release Experiments  with the 
Posterior Pituitary 
Posterior pituitaries were  removed from  rats  which 
had  been  injected in  the  SON  with ~S-cysteine  24  h 
before and suspended at 37"C in normal saline solution 
(composition  in  raM/liter:  130  NaCI,  5.4  KCI,  1.3 
CaCI2, 0.8 MgSO4,  10 mM N-2-hydroxyethylpiperazine- 
N'-2-ethane sulfonic acid [HEPES], and 10 mM glucose) 
equilibrated  with  95%  O~,  5%  COs.  All  incubating 
solutions were  adjusted  to  pH  7.3-7.4  and  335-340 
mosmoi/liter with  NaCI  and  contained  bovine  serum 
albumin (1 mg/ml). The pituitaries were then incubated 
in the above-described medium at 37~  for a total of 30 
rain (each pituitary was incubated in a separate Falcon 
microtest culture dish well in 100 p,1 of medium for 10 
min,  and  transferred  to  a  new  well  containing fresh 
medium). The medium from the final 10-min incubation 
was made 0.1  M with HCI and saved for analysis. The 
TCA-precipitable and-soluble cpm in this sample is re- 
ferred to as the "basal release" in the text. The pituitar- 
ies were then transferred consecutively to wells contain- 
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medium, and high K+-Ca++-containing medium (incuba- 
tion periods were 10 min each, for a total of 20 rain in 
each medium). The composition of the normal K+-Ca  +§ 
free medium (in mM/liter) was 130 NaCI, 5.4 KC1, 0.8 
MgSO4, 4.2 MgClz,  1 Na-ethylene glycol-bis(fl-amino- 
ethyl ether)N,N,N',N'-tetraacetate  (EGTA),  10  mM 
HEPES,  and  10  mM  glucose;  the  high K+-Ca++-free 
medium was the same except that NaCI was lowered to 
51 mM and the KC1 was raised to 80 mM; the high K +- 
Ca++-containing medium  was  the  same  as the  normal 
saline  solution  (see  above)  except  that the  NaC1  was 
lowered to 51 mM and the KCI raised to 80 raM. Each 
medium was acidified with HC1  (to a  concentration of 
0.1 M HCI), and the pituitary (after the experiment) was 
homogenized in 0.1  M  HC! as described above. TCA- 
precipitable and-soluble cpm was determined from each 
of the medium samples, and was expressed as a fraction 
of the  basal  release  into the  medium  (per  10  min  of 
incubation). The  labeled proteins and  peptides in the 
release medium, i.e., the high K+-Ca++-containing me- 
dium, were analyzed by acid-urea gel electrophoresis and 
thin-layer  chromatography,  respectively,  as  described 
above. 
Analysis of Radioactivity 
Polyacrylamide gels in tubes were sliced by conven- 
tional methods and processed for their radioactivity as 
described elsewhere (24). Slab gels were dried in a Bio- 
Rad  slab gel drier  (Bio-Rad Laboratories, Richmond, 
Calif.) onto 3 MM Whatman filter paper, covered with 
X-ray film (Kodak Royal X-Omat film, CGR  Medical 
Associates, Rockville, Md) and exposed at -70"C (4). 
The radioautograms were scanned with an E-M densi- 
tometer (EM Laboratories, Inc., Elmsford, N. Y.) for a 
qualitative representation of the radioactive pattern on 
the gels, and quantitative data were obtained by slicing 
out the radioactive bands of interest, solubilizing them in 
an appropriate cocktail (54), and counting their radioac- 
tivity in a Beckman liquid scintillation counter (Beckman 
Instruments,  Inc.,  FuUerton,  Calif.).  Radioactivity  in 
each band was expressed as a percentage of total cpm on 
the gel. 
The TCA-precipitable and-soluble cpm of the tissue 
and  media  were  obtained  by  conventional techniques 
using Whatman 3 MM filter paper pads for TCA precipi- 
tation. The counting efficiency for asS was 68% and the 
background was 18 cpm. 
RESULTS 
Incorporation  o  f as  S-Cysteine into 
Neurohypophysial Proteins and Their 
Axonal Transport to the 
Posterior  Pituitary 
The  time-course  of  appearance  of  S%-labeled 
protein, i.e., TCA-precipitable cpm, in the various 
regions of the hypothalamo-neurohypophysial sys- 
tem is shown in Fig. 1. The data in Fig. 1 A  (filled 
circles, solid line) show that, at 30 min after injec- 
tion of ssS-cysteine  into the SON,  about 30%  of 
the  radioactivity  in  the  SON  region  was  TCA 
precipitable,  and  that this  value  did  not change 
significantly until about  6  h  postinjection.  Thus, 
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FIGURE  t  Time-course  of  appearance  of  a~S-labeled 
proteins in the supraoptic nucleus (A), median eminence 
(B), and posterior pituitary (C) after a bilateral microin- 
jection of ~S-cysteine into the SON of female rats. Filled 
circles show data from control rats; open circles repre- 
sent data from rats which were intraventricularly injected 
with colchicine 12 h before injection of the a~S-cysteine. 
Note that although there is considerable labeled protein 
in the SON after 30 rain, labeled protein first appears in 
the median eminence only after 1 h, and in the posterior 
pituitary after 2 h. In addition, the appearance of axon- 
ally transported labeled protein is inhibited by colchicine 
(B) and (C), whereas the percent of incorporation in the 
SON was unaffected (A) by colchicine. The incorpora- 
tion into the SON (A) is expressed as the fraction of total 
cpm  in the punched tissue that was TCA  precipitable 
(PPT'L).  In (B) and (C) the TCA-precipitable cpm in 
the tissue was expressed as a fraction of the TCA-precipi- 
table cpm in the punched SON sample of the same rat. 
Data (filled circles) are expressed as means -+ standard 
deviations. The number of experiments for each time- 
point is shown in (C). 
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the  SON  was  very  rapid,  and  approximated  a 
pulse incubation. 
Labeled proteins did not appear at the level of 
the ME (Fig. 1 B, solid line) until  1 h post-injec- 
tion, and rose rapidly between 1 and 2 h, reaching 
a maximum at about  12 h. In the posterior pitui- 
tary (Fig.  1 C, solid line),  labeled  proteins were 
first detected at 2 h and rose rapidly to a maximum 
value  at  12  h. These  kinetic data  are  consistent 
with the notion that the proteins are first synthe- 
sized  in  the  SON  region  and  then  transported 
intra-axonally to the posterior pituitary via axons 
traversing the median eminence. The time lag of 
60-120  min  between  injection  in  the  SON  and 
arrival of labeled proteins in the posterior pituitary 
is comparable to values found by others in similar 
experiments with rats (32, 36) and consistent with 
the expected axonal transport rates of neurohypo- 
physial  proteins  (see  Table  4  in  reference  52). 
Further evidence for the role of axonal transport 
in  the  arrival  of labeled  proteins  in  the  median 
eminence and posterior pituitary comes from the 
colchicine studies shown in Fig. 1. Colchicine, an 
inhibitor of axonal transport (10, 19, 20, 26), was 
injected  into  the  lateral  ventricles  (100  p.g dis- 
solved in  10  /zl of 0.9%  NaCi)  12  h  before the 
bilateral  injection of 35S-cysteine in the rat SON. 
Although this colchicine treatment did not appre- 
ciably affect 35S-cysteine  incorporation  into  pro- 
teins  in  the  SON  (Fig.  1 A,  broken  line),  the 
appearance  of labeled  proteins  in  the  ME  (Fig. 
1 B, broken line) and posterior pituitary (Fig. 1 C, 
broken  line)  was  dramatically  reduced.  Similar 
effects of colchicine on axonal transport of neuro- 
hypophysial principles were demonstrated by Nor- 
strom (31) and Sachs et al. (45). 
Analysis  of Proteins Transported to 
the Posterior Pituitary 
In an attempt to evaluate the diversity of pro- 
teins  transported  to the  posterior  pituitary  after 
3~S-cysteine injection into the SON, we separated 
the labeled  proteins from the posterior pituitary 
(24  h  post-injection)  by  using  four  different 
PAGE systems (see Materials and Methods). 
The results of these separations are illustrated in 
Fig. 2. Fig. 2 A  shows that the pattern of labeled 
proteins transported to the posterior pituitary was 
relatively simple with  electrophoresis on pH 9.5 
gels.  Only one  major  peak  of radioactivity was 
detected.  Separation  of the  labeled  neurohypo- 
physial proteins on acid-urea gels (pH 2.7 gel) also 
revealed only one major radioactive  peak which 
migrated on the gel between bovine neurophysins 
I and II (Fig. 2 B). We believe that these labeled 
peaks (Fig. 2 A and B) represent transported neu- 
rophysin(s) for several reasons.  (a) Neurophysin 
is  known  to  be  the  major  cysteine-rich,  acidic 
protein transported to the posterior pituitary (16). 
A  similar  labeling pattern  of transported  neuro- 
physins has been reported by Norstrom et al. (33) 
using a gel system comparable to our pH 9.5 gel 
system. (b) These radioactive protein peaks were 
highly soluble in alcohol, just as has been reported 
for neurophysin (1, 25, 55). (c) The labeled peak 
found on acid-urea gels (Fig. 2 B) corresponds in 
migration position on the gel to a major Coomas- 
sie  Blue-stained  band,  which  is  specifically  de- 
creased  in  staining  intensity  when  the  rats  are 
osmotically stressed by 2% NaCI in their drinking 
water  (Fig.  3).  (d)  These  labeled  proteins  are 
released from the pituitary by potassium depolari- 
zation in the presence of calcium (see later) as is 
expected for neurophysin (12). 
With  regard  to  the  salt  treatment  of the  rats 
mentioned above, it is of interest to note that the 
labeling pattern  shown in Fig. 2 B  was the same 
independent  of  whether  the  experiments  were 
done on  normal  or salt-treated,  i.e.,  after  5-10 
days  of exposure  to  2%  NaCI  in  the  drinking 
water, rats. The only difference was that the abso- 
lute  cpm  in  the  peak  from  salt-treated  rats  was 
about fourfold greater than that from normal rats. 
This was probably due to the fact that salt-treated 
rats incorporated four times more ~S-cysteine into 
SON  proteins  and  transported  four times  more 
labeled protein to the pituitary in 24 h than  nor- 
mal rats (Table I). In the Coomassie Blue-staining 
patterns  shown  in  Fig.  3,  at  least  seven  major 
stained bands were detected by acid-urea PAGE 
of proteins from normal rat  pituitary.  However, 
only the  most rapidly  migrating  band  contained 
35S-labeled  proteins.  Consistent with this was the 
observation that this stained band selectively dis- 
appeared  with salt  treatment,  although the same 
radioactive peak was still present. Since both vaso- 
pressin and oxytocin are depleted in the posterior 
pituitary  of rats  after  prolonged  osmotic  stress 
(18), it is possible that both the vasopressin- and 
oxytocin-associated  rat  neurophysins,  which  ap- 
pear to be distinct proteins (5,37,48), comigrated 
in this gel system. In this regard, it is important to 
note that we have detected both ~S-labeled argi- 
nine  vasopressin  and  oxytocin  in  the  posterior 
pituitary 24 h after injection of 35S-cysteine in the 
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FIGURE 2  Polyacrylamide gel electrophoresis (PAGE) of asS-labeled proteins extracted from rat pituitar- 
ies 24 h after injection of ~S-cysteine into the SON. (A) Disc PAGE (7.5% acrylamide) in a pH 9,5 
(running pH) system. Internal marker protein was bovine serum albumin (BSA). (B) Disc PAGE (7.5% 
acrylamide) in a pH 2.7 system (acid-urea gel). Internal markers: BSA; bovine neurophysins I and II, bNPt 
and bNPxl. (C) Isoelectric focusing (IEF) (7.5% acrylamide) with pH 3-10 ampholytes. The broken line 
shows the actual pH gradient measured  using a co-run gel. (D) Disc PAGE in sodium dodecyl sulfate 
(SDS). Upper abscissa shows slice positions of internal marker proteins of known molecular weight, and 
arrow shows position of bNP~ and bNP. in a co-run gel. Polyacrylamide concentration  of gel was 11%. 
SON (see Fig. 8). The ratio of labeled vasopressin 
to  that  of oxytocin  in  the  neurohypophysis was 
about 1.8 in our experiment, which was compara- 
ble to the value of 1.49 obtained by Burford et al. 
(6)  for  the  ratio of radioactivity in  vasopressin- 
neurophysin to that in oxytocin-neurophysin after 
intracisternal injections of 35S-cysteine. 
In view of our inability to resolve more than one 
major radioactive pituitary peak with the above- 
described gel systems, which separate proteins on 
the basis of both electrical charge and molecular 
size properties, we turned to IEF separation pro- 
cedures. Fig. 2 C shows the results of such experi- 
ments.  The  labeled  neurohypophysial  proteins 
electrofocused principally in the acidic region of 
the gel ranging in isoelectric points from pH 4.5 to 
5.2  with  the  peak  value  at  about  pH  4.8.  In 
subsequent IEF experiments using expanded pH 
gradients on  the gel, i.e., from pH 3.5  to 7,  we 
found that the labeled neurohypophysial proteins 
are represented by two distinct closely migrating 
peaks with pI values equal to 4.6 and 4.8. These 
may correspond to the two  rat neurophysins re- 
ported by Burford and Pickering (5) who used a 
different separation procedure. 
Separation  of  the  labeled  neurohypophysial 
proteins by PAGE in SDS showed that the trans- 
ported proteins were of relatively low molecular 
weight (Fig. 2 D). Similar findings that the trans- 
ported,  labeled  neurohypophysial  proteins 
showed a peak on SDS gels at around 12,000 mol 
wt (ranging between  10,000 and  14,500  mol wt) 
have been reported by others (31, 33). It should 
be pointed out that, although the peak in Fig. 2 D 
comigrated with  the  12,000-tool wt marker-pro- 
tein  in  the  gel,  bovine  neurophysins  I  and  II 
(which are about 10,000 mol wt) also comigrated 
with this marker-protein (see arrow in Fig. 2 D). 
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Synthesized in the Hypothalamo- 
Neurohypophysial System 
In the preceding section, it was shown that the 
principal 35S-cysteine-labeled proteins (neurophy- 
sins)  transported to  the  posterior pituitary were 
represented by a single rapidly migrating peak on 
acid-urea gels. Since the biosynthetic process is in 
the neuronal perikarya (15, 16, 22, 44) located in 
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FmURE  3  Diagram  of Coomassie  Blue-stained  bands 
of proteins extracted from posterior pituitaries of normal 
rats and rats that had been drinking 2% NaC! for 10 days 
(salt treated), which were separated by electrophoresis 
on 15% acid-urea gels. Note disappearance  of the most 
rapidly migrating band after salt treatment. Arrows de- 
note migration positions of cytochrome c, bovine neuro- 
physins I and II in co-run gels. 
the SON and PVN of the hypothalamus, we ana- 
lyzed the labeling profiles of proteins, separated 
on acid-urea gels, which were extracted from the 
SON  at  various times  after injection of 3%-cys- 
teine.  In these  experiments the  labeled proteins 
were electrophoresed on acid-urea slab gels (15 % 
acrylamide) and  radioautographed. Fig. 4  shows 
autoradiograms  of  such  gels  containing  labeled 
proteins from the SON and posterior pituitaries of 
salt-treated rats. These autoradiograms were over- 
exposed  in  order  to  emphasize  that  only  one 
highly labeled, rapidly migrating peak is found in 
the  pituitary  after  24  h,  in  comparison  to  the 
complex Coomassie Blue-staining pattern of pitui- 
tary  proteins shown  in  the  same  figure  (Fig. 4, 
COOM.  BLUE). In contrast to the posterior pi- 
tuitary data, the SON labeling pattern,  1 h post- 
injection,  shows  a  heavy  zone  of  radioactivity 
(composed of two different peaks) with a  lower 
migration rate  on  the  gel than  the  neurophysin 
peak. At 24 h postinjection, this zone of radioac- 
tivity virtually disappeared from the SON (Fig. 4). 
The  data in Fig. 5  show  the  results of a  time 
study of the labeling patterns found in the SON, 
ME, and posterior pituitary after injection of 35S- 
cysteine in the SON of normal rats. In these exper- 
iments,  the  autoradiograms of the gels were  ex- 
posed for shorter times in  order to improve the 
resolution of the individual bands of radioactivity. 
The  autoradiograms were  then  densitometrically 
scanned  to  produce  the  traces shown  in  Fig.  5. 
Several peaks with distinct Rr  values can be dis- 
cerned in Fig. 5,  and have been designated a-g. 
Specific peaks of interest were cut out of the gel 
and counted for their radioactivity by liquid scintil- 
lation counting techniques. 
1 h postinjection, the SON labeling profile was 
dominated by two closely migrating peaks a and b 
TABLE  I 
Effects of Salt Treatment on the Incorporation of ~S-Cysteine into SON and Posterior Pituitary Proteins* 
Tissue  Time  Control  Salt-treated  Ratior  pw 
h  cpm xlO 3 
SON  1  129  -+  34  (9)  565  ---  73  (9)  4.4  <0.001 
Posterior  pitui-  24  147 -  39 (6)  585  +- 97 (6)  4.0  <0.001 
tary 
* Female rats were given 2% NaC! to drink for 5-7 days (salt-treated), in comparison to normally treated (control) 
female rats. The rats were injected with ~S-cysteine in the SON (bilaterally), and SON (1 h after injection) and 
posterior pituitaries (24 h after injection) were taken for analysis of their TCA-precipitable  cpm. Data are expressed 
as means -+ SEM. Number of experiments is shown in parentheses. 
r Ratio of salt-treated CPM/control  CPM. 
w  p Value determined by Fisher t test for small numbers. 
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(COOM. BLUE)-staining patterns of SON and pituitary 
(PIT) proteins electrophoresed on  15%  acid-urea  slab 
gels. The  radioactive  proteins were  obtained from  ex- 
tracts  of tissues from  salt-treated female  rats (5 days), 
whereas the Coomassie Blue-stained  gel contained pos- 
terior pituitary proteins from a normal (control) female 
rat.  The  Coomassie  Blue  band  corresponding  to  the 
labeled peak generally appears less densely stained  on 
slab  gels  than  on  disc  gels  shown  in  Fig.  3.  Arrows 
designate  migration positions of bovine serum albumin 
(BSA) and cytochrome c (Cyt. c) marker proteins co-run 
on the same slab gel. 
of radioactivity (Fig.  5 A),  with  migration  rates 
much lower than that of the labeled neurophysin 
peak arriving in the pituitary at 24 h, i.e., peak e 
in  Fig.  5 C.  Note  that  two  other minor compo- 
nents, land g, could also be detected in the 24-h 
posterior  pituitary  using  autoradiographic  tech- 
niques. Hence, after 1  h,  only 8.4%  of the total 
radioactivity in the  SON appeared in the rapidly 
migrating  peaks,  i.e.,  peaks  d  and  e,  whereas 
72.6% of the cpm resided in peaks a and b. As can 
be seen in Fig. 5 B and C, the relative radioactivity 
in peaks a  and b continued to decrease, while that 
of peaks d  and e increased with time. In compari- 
son, there appeared to be relatively little change in 
peak  c  with  time.  The  above-described events 
appeared to occur in an identical fashion in both 
male  and female rats which  were  induced to in- 
crease their neurohypophysial activity by drinking 
2%  NaCI (unpublished data). 
The apparent decrease in radioactivity"  in peaks 
a  and b  simultaneous with the increase in relative 
radioactivity of peaks d  and e in the SON, in such 
a  "pulse"  label  paradigm,  is  consistent  with  a 
precursor-product relationship between these pro- 
teins. Since neurophysins are known to be synthe- 
sized by neurons in the SON (22, 44), and appear 
to correspond to the labeled peak e  in the  SON 
and pituitary after 24 h  (Fig. 5), then peaks a  and 
b  may  represent  the  protein  precursors  of  the 
oxytocin-related  and  vasopressin-related  neuro- 
physins. Since peak d  is only found in the SON at 
short times after the injection of 3sS-cysteine, it is 
possible that this may be a  short-lived intermedi- 
ate in the conversion of the precursor proteins to 
neurophysin. In  order to  determine whether the 
labeled peaks (a and b) were greater in molecular 
weight  than  the  presumed  product  (peak e),  la- 
beled proteins extracted from the SON and poste- 
rior pituitary  1  and  24  h  post-injection, respec- 
tively,  were  electrophoresed  on  acid-urea  gels. 
Peaks a  +  b, c, and e were located on the gels, cut 
out,  eluted,  and  evaluated  for  their  apparent 
molecular  weights  by  three  different  methods: 
Sephadex G-75 chromatography, PAGE in SDS, 
and Ferguson plot analysis (9, 24, 39) of acid-urea 
gels. The results of all three methods were in close 
agreement  (Table  II),  showing  the  molecular 
weights of the putative precursors (peaks a  and b) 
and neurophysins (peak e)  to be  19,000-20,000 
mol wt and  12,000-13,000  tool wt, respectively. 
SON  b  B  MEDIAN  EMINENCE 
,h 
L  2h  ~  e 
I~OURE  5  Densitometric  tracings  of  autoradiographs 
of 15 % acid-urea slab gels on which ~S-labeled proteins 
from the SON, median eminence, and posterior pituitary 
were  electrophoresed. Normal male rats were  injected 
with asS-cysteine into the SON, and tissues were taken 
for analysis at various times postinjection (1-24 h). The 
letters a-g  shown  over  the  tracings  correspond  to 
distinct radioactive peaks in the autoradiographs. 
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Molecular Weight and lsoelectric Point Determina- 
tions of  the Putative Precursors and Neurophysins in 
the Rat* 
Ferguson 
Protein  G-75  plot  SDS  IEPw 
Precursors 
(peaks a  + 
b) 
Intermediates 
(peak c) 
Neurophysins 
(peak e ) 
tool wt (x  lO-S)r 
19  20  20  5.4, 6.1 
15  -  15  5.1, 5.6 
12  13  12  4.6, 4.8 
* Labeled proteins were  extracted from  the SON and 
posterior pituitary of salt-treated rats after 1 and 24 h 
postinjection, respectively, and electrophoresed on acid- 
urea gels. The labeled peaks from the SON (represented 
by peaks a, b, and c in Fig. 5 A) and one labeled peak 
from the pituitary (peak e in Fig. 5 B) were eluted from 
the gels and analyzed. 
~: Molecular weights of the isolated labeled peaks a, b, c, 
and e were determined by three independent methods: 
(a) chromatography  using Sephadex G-75, (b) Fergu- 
son  plot analysis of acid-urea  gels,  and  (c)  SDS gel 
electrophoresis. 
w  Isoelectric points (IEP) of the isolated proteins were 
determined by isoelectric focusing of peaks a, b, c, and e 
on polyacrylamide gels. Each peak eluted from the acid- 
urea gel run appeared to be heterogeneous.  Two major 
peaks of radioactivity were found each for the precursor 
(a + b ), the intermediate (c), and the neurophysin (e). 
Therefore, these data are consistent with the pro- 
posal that peaks a  and b  represent precursors of 
the  labeled proteins in  peak e.  As pointed  out 
earlier, peak e  actually contains two major, dis- 
tinctly labeled proteins as revealed by IEF (pI 4.6 
and 4.8; Table II), and peaks a  and b  also run as 
two independent labeled peaks with pI values of 
5.4  and  6.1  on  IEF  gels  (Table  II).  The  data 
represent necessary but not sufficient evidence to 
prove  the  identity  of  a  precursor,  and  further 
experiments (see Discussion) are clearly necessary 
for this purpose. However, we have observed, in 
the  SON,  a  biosynthetic process consistent with 
the requirements of a precursor-product relation- 
ship, and tentatively propose that peaks a  and b 
represent  the  precursors  to  the  neurophysins 
found in peak e. 
Axonal  Transport and Post-Translational 
Processing of the Putative Precursor 
Although peak e in the SON increases in radio- 
activity as peaks a and b decrease (Fig. 5 A), peak 
e never attains the level of radioactivity  expected if 
there were simply a conversion of a  and b  to e in 
the SON, i.e., at 1 h a  and b  =  72.6%, whereas 
the maximal value attained in the SON (at 24 h) 
for peak e  =  28.5%. The data illustrated in Fig. 
5 A  suggest that a  significant amount  of peaks a 
and b  is transported out of the SON, presumably 
into  the  axons,  before  conversion  takes  place. 
Indeed,  on  the  basis  of  other  data,  Sachs  and 
colleagues (44) had hypothesized that the conver- 
sion of the precursor takes place in the axon dur- 
ing axonal transport. This hypothesis is supported 
by the data illustrated in Fig. 5 B  and C. At early 
times postinjection (e.g., 1-2 h), when the puta- 
tive precursor is heavily labeled in the SON (Fig. 
5 A), one might expect that the labeled proteins in 
the axon  (derived from  axonal transport of pro- 
teins  from  the  neuronal  somata  in  the  SON) 
should contain significant labeled precursor. How- 
ever, at later times, i.e., 24 h postinjection, when 
virtually only labeled neurophysin is present in the 
SON,  the  axonally transported  proteins  should 
contain principally labeled neurophysin. These ex- 
pectations are borne out by the data shown in Fig. 
5 B. 2  h postinjection, the labeling profile in the 
median eminence, an area rich in axons from the 
SON, indicates that about 40% of the radioactiv- 
ity is in the precursors (Fig. 5 B, peaks a and b). If 
one considers the time delay between synthesis in 
the SON and transport to the axons in the ME, it 
is apparent that the labeled proteins arriving after 
2 h in the ME (Fig. 5 B) must have been derived 
from  the  population  of  labeled  proteins  in  the 
SON after about 1 h  (Fig. 5 A). Hence, the pre- 
cursor to product conversion process, resulting in 
the labeling pattern seen in Fig. 5 B  (2 h), must 
have occurred intra-axonally during transport. 24 
h  postinjection, the  ME labeling profile displays 
virtually only neurophysin  (Fig.  5 B),  consistent 
with the pattern seen in the SON at that time (Fig. 
5 A). A  similar sequence of events appears to be 
evident  for  the  axon  terminals  in  the  posterior 
pituitary (Fig. 5 C). 
Peptides  Transported to the 
Posterior Pituitary 
If one assumes that the 19,000-20,000-mol wt 
putative  precursor  is  converted  to  a  12,000- 
13,000-moi wt neurophysin during axonal trans- 
port, one might expect to find other peptide prod- 
ucts (in addition to the 1,100-moi wt vasopressin 
and oxytocin) as a result of the post-translational 
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ined the diversity of 35S-cysteine-labeled peptides 
which are synthesized in the SON and transported 
to the posterior pituitary. 
Fig.  6  depicts  the  results  of Sephadex  G-25 
chromatography of the TCA-soluble fraction from 
a  posterior pituitary  24  h  after injection  of asS- 
cysteine  in  the  SON.  The  labeled peptides  are 
represented  by  a  broad  peak  corresponding  to 
molecular weights ranging from 700 to 2,500 mol 
wt. Note that there is no asS-label which  coruns 
with the riboflavin marker (RIBO, Fig. 6), which 
indicates that no free asS-cysteine or its oxidized 
by-products are transported to the pituitary. Simi- 
lar labeling profiles were obtained from the TCA- 
soluble fractions from the SON (1 and 24 h postin- 
jection) after Sephadex G-25 separation. 
The labeled peptides from the G-25 separations 
were lyophilized and spotted on a cellulose  (TLC) 
plate and subjected to two-dimensional TLC. The 
results of the TLC separations are illustrated  in 
Fig. 7. Fig. 7 shows a peptide map of asS-labeled 
peptides found in either the SON or the posterior 
pituitary.  18  distinct  spots  containing  asS-label 
could be detected in the hypothalamo-neurohypo- 
physial system. One  of these  spots  (spot 8)  ap- 
pears to be more heavily labeled in the posterior 
pituitary than either oxytocin (spot 13) or arginine 
vasopressin (spot 11). That is, of the 103,722 cpm 
in labeled peptides from the 24-h posterior pitui- 
tary spotted  on  the  TLC plate,  the  labels con- 
tained (expressed as a percentage of total cpm) in 
spots 4, 5, 6, 8, 11, 13, and 14 were 3.2, 8.2, 0.7, 
33.0, 25.6,  14.0, and 4.7%. Although the func- 
tional significance of these spots and their relative 
abundance  are still  undetermined,  it is apparent 
from these data that many more peptides, other 
than the known neurohypophysial hormones oxy- 
tocin and vasopressin, are synthesized in the SON 
and transported to the posterior pituitary. 
A  similar chromatographic analysis  of the  la- 
beled  peptides  found  in  the  SON  1  and  24  h 
postinjection was made. The distribution of label 
in the 1-h SON peptides was 7.3, 12.6, 1.9, 56.1, 
6.1, 1.4, and 0.5% (expressed as a percentage of 
121,102 cpm spotted) for spots 4, 5, 6, 8, 11, 13, 
and  14, respectively; whereas for the 24-h SON 
peptides,  the  distribution  of label was 7.5,  6.1, 
2.6,  52.7,  11.6,  1.6,  and  0.1%  (102,950  cpm 
spotted). Thus, the ~S-labeled spots numbered 4, 
5, 8, and 11 (Fig. 7) contained substantial radioac- 
tivity in the SON at both 1 and 24 h. Since both 
arginine vasopressin (AVP) and oxytocin (OXY) 
are found in the SON (49),  it is of interest that 
spot 11 (AVP) increased in radioactivity, whereas 
spot 13 (OXY) did not increase in radioactivity in 
the SON after 24 h (as compared to 1 h postinjec- 
tion). However, in the posterior pituitary (24 h), 
spot  13  contained  a  substantial  amount  of the 
label. The appearance of substantial radioactivity 
in vasopressin (spot 11) but not oxytocin (spot 13) 
in the SON (after 24 h) is consistent with previous 
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FIGURE  6  Sephadex-G25  separation  of TCA-soluble, labeled peptides in the posterior pituitary  24 h 
after injection of asS-cysteine  into the SON. Vo, Ve, and V t represent the void, excluded, and included 
volumes,  respectively. Arrows  show  the  fractions  corresponding  to  arginine vasopressin  (AVP)  and 
riboflavin  (RIBO). 
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FIGURE 7  Labeled peptide  map obtained  by two-di- 
mensionai TLC of TCA-soluble, labeled peptides in the 
posterior pituitary 24 h postinjection. Spots numbered 
11 and 13 correspond to arginine vasopressin  and oxyto- 
cin, respectively. See text. 
suggestions that  the  precursor  to  vasopressin is 
processed more rapidly than that to oxytocin (23, 
53). 
Release of Labeled Peptides from the 
Posterior Pituitary 
The diversity of labeled peptides found in the 
pituitary after  a~S-cysteine injection in the  SON 
raises  the  question  whether  these  peptides  are 
released from the posterior pituitary by depolari- 
zation of the  nerve terminals in the presence of 
extracellular calcium. In these  experiments, a~S- 
cysteine was injected into the SON of normal rats, 
as opposed to salt-treated rats, in order to mini- 
mize the release of neurohypophysial principals in 
vivo. 24 h postinjection, the posterior pituitaries 
were  removed  from  the  rats  and  incubated in 
saline containing normal levels of K + and Ca  § 
(see  Materials  and  Methods).  These  pituitaries 
were then transferred and incubated serially in the 
various media in the  following sequence: a)  5.4 
mM K +,  1.3 mM Ca  ++ (basal release media), b) 
5.4 mM K §  0 mM Ca  ++ (+ 1 mM EDTA), c) 80 
++  mM K §  1.3 mM Ca  . The TCA-precipitable and 
-soluble cpm released from the pituitaries into the 
soluble cpm  released from  the  pituitries into the 
various media were determined and expressed as a 
fraction of the release from the same tissue in the 
basal release medium. The data are illustrated in 
Fig. 8. There was no increase in TCA-soluble or 
-precipitable clam released over basal release by 
pituitaries depolarized by 80 mM K § in the absence 
of Ca  ++.  However, there was a  twofold increase 
in TCA-soluble cpm and a  threefold  increase in 
TCA-precipitable cpm when Ca  ++ (1.3 raM) was 
added to the medium containing 80 mM K + (Fig. 
8A and B). Between 2 and 5% of the total cpm 
in the posterior pituitary was released by the cal- 
cium-dependent, potassium depolarization of the 
terminals. 
Analysis of the TCA-precipitable cpm released 
into the 80 mM K +, 1.3 mM Ca  §  medium after 
electrophoresis on acid-urea gels revealed a  pat- 
tern identical to that shown in Fig. 2 B. The TCA- 
soluble cpm  in the  80  mM  K +,  1.3  mM  Ca  § 
medium and pituitaries were spotted for two-di- 
mensional TLC as described earlier. The results of 
this  analysis  showed  that  the  labeled  peptides 
which were released into the medium were com- 
parable to those found in the posterior pituitary, 
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FIGURE 8 
TCA  SOL. 
§ 
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1.3 Cc 
Release of labeled peptides by calcium-de- 
pendent, potassium depolarization of the posterior pitui- 
tary (24 h after injection of asS-cysteine  into the SON of 
normal rats).  (A)  TCA-soluble (SOL.) peptides.  (B) 
TCA-precipitable (PPT.) peptides. Data are expressed 
as cpm released per cpm basal release, i.e., basal release 
refers to the cpm appearing in the medium in the pres- 
ence of 5.4 mM K  +, and  1.3 mM Ca  ++ . See text for 
details of experiments. The K  + and Ca  ++ concentration 
of each medium is shown within the bars in the figure. 
The data are expressed as the average value _+ SEM. of 
13 experiments. 
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Fig.  7.  The  principal  released  peptides  corre- 
sponded to the spots numbered 4, 5,  8,  11,  13, 
and  14,  which  contained  2.7,  9.3,  24.5,  14.8, 
19.0, and  14.6%, respectively, of the total label 
spotted (1,200 cpm). Therefore, the labeled pep- 
tides transported to the posterior pituitary appear 
to be  accessible  to the release  mechanism in the 
nerve terminals. 
DISCUSSION 
Biosynthetic Evidence for a Precursor 
of Neurophysin 
The initial  step in the identification of a precur- 
sor is the demonstration in a pulse label paradigm 
that  a  labeled  polypeptide  of higher  molecular 
weight is first synthesized and then  decreases in 
radioactivity in time as the lower molecular weight 
labeled peptide (or peptides) is formed. Since the 
biosynthetic process for neurophysin and neurohy- 
pophysial hormones is located in the hypothalamic 
nuclei,  we analyzed the labeling profiles of pro- 
teins  extracted  from  the  SON  at  various  times 
after injection of a~S-cysteine by PAGE. 1 h after 
injection of a'~S-cysteine, the SON labeling profile 
was dominated by two closely migrating peaks of 
radioactivity, i.e., peaks a  and b, Fig. 5 A, corre- 
sponding to proteins of about 20,000 mol wt (Ta- 
ble II). These labeled peaks decreased in radioac- 
tivity with time, as the 12,000 mol wt neurophysin 
peak  (peak e,  Fig.  5 A) relatively increased.  As 
was pointed out earlier, the decline in radioactivity 
in  the putative  precursor peaks in the SON was 
probably due to two factors: (a) the conversion of 
the  precursor peaks to  neurophysin and  (b)  the 
axonal transport of the precursor out of the neu- 
ronal perikarya in the SON (the evidence for this 
comes from the observation of precursor peaks in 
the regions of the axons, i.e., the ME and poste- 
rior  pituitary  (Fig.  5 B  and  C).  Thus,  we  have 
observed in the SON, a biosynthetic process con- 
sistent with the expectations of a precursor-prod- 
uct relationship between peaks a and b and peak e 
(which upon IEF reveals two labeled peaks). Be- 
cause of these data, we propose that peaks a and b 
represent  the  putative  precursors for the  neuro- 
physins,  and  presumably  the  neurohypophysial 
peptides. 
Data such as those presented above represent 
necessary but not sufficient proof for the identity 
of a  precursor.  Further  immunological,  peptide 
mapping (after limited proteolysis) and ultimately 
amino  acid  sequencing  studies  are  dearly  re- 
quired, and are currently underway in our labora- 
tories. In a recent report (27), specific antibodies 
to vasopressin  and  its  associated  neurophysin  in 
the rat were used to measure the content of these 
molecules in the neurohypophysis and hypothala- 
mus. In contrast to the neural lobe which had  a 
neurophysin:vasopressin ratio of about 1, the hy- 
pothalamic ratio was >2. The authors concluded 
that  this  finding  would  be  compatible  with  the 
presence  of a  common precursor  protein  which 
had  a  higher affinity for neurophysin than vaso- 
pressin antiserum. In recent immunoprecipitation 
experiments,  we found that  the putative  labeled 
precursors (peaks a  +  b), intermediates (peak c), 
and neurophysins (peak e) are all specifically im- 
munoprecipitated by antibodies to rat neurophy- 
sin? Thus, there  appears to be significant amino 
acid sequence homology between the putative pre- 
cursors, intermediates,  and neurophysin, thereby 
strengthening  the  case  for  identification  of the 
precursors.  Furthermore,  the apparent heteroge- 
neity in  the  labeled  precursor peak  (a  +  b)  re- 
vealed by IEF (Table II) has been clarified by our 
recent experiments on rats homozygous for diabe- 
tes insipidus.  Pulse-labeling experiments in these 
vasopressin-deficient rats have shown that only the 
labeled 5.4 pI precursor, 5.1 pI intermediate, and 
4.6 pI neurophysin were synthesized (see Table II 
for pI values found in normal rats). Thus, it would 
appear that the precursor for the oxytocin-related 
neurophysin has a pI =  5.4, whereas the vasopres- 
sin-related precursor has a pI =  6.1. 
Post-Translational Modification 
during Axonal Transport 
The data illustrated in Fig. 5 B and C show that 
the earliest arriving labeled proteins in the median 
eminence  and  pituitary  contain  significant 
amounts of labeled putative precursor. However, 
at  later  times,  only  labeled  neurophysins  were 
found. This suggests that the precursors are pack- 
aged  in  a  translocatable  compartment  (e.g.,  the 
neurosecretory granules)  and therefore, may un- 
dergo post-translational  cleavage to the products 
intragranularly  during axonal transport. A  hypo- 
thetical model of this phenomenon is presented in 
Fig. 9. 
Brownstein, M. J., A. G. Robinson, and H. Gainer. 
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FIGURE 9  Hypothetical  model of biosynthesis,  translocation,  processing, and release of peptides in a 
peptidergic neuron. Translation of mRNA occurs on the rough endoplasmic reticulum  (R. E. R.) in the 
neuron soma yielding a propeptide or precursor protein molecule (P~) in the cisternal space of the R. E. R. 
The packaging of P~ into secretory granules occurs in the Golgi body. The secretory granule represents the 
site of post-translational processing to smaller peptide products (P~... P,) which can occur either in the 
neuron soma or in the axon during axonal transport. The peptide products (P~) are released from the 
neuron terminals by depolarization in the presence of extracellular calcium. 
In addition to this evidence, several other lines 
of  evidence  suggest  that  the  processing  of  the 
precursor  occurrs  intragranularly  during  axonal 
transport.  Sachs (41) found that  the vasopressin 
content of granules in the neurohypophysis is five- 
fold greater than  in the hypothalamus, and sug- 
gested that the generation of vasopressin from the 
precursor occurs principally in a region in between 
the perikarya in the hypothalamus and the neural 
lobe, i.e., in the axon. More recently, morphologi- 
cal evidence in support of intragranular processing 
has been  reported. Using a  triple aldehyde fixa- 
tive,  Morris  and  Cannata  (28)  found  that  the 
dense  core  or  neurosecretory  granules  in  the 
neural lobe was best preserved at pH 5.0-6.0, but 
that a marked loss of density of the granule core 
occurred at pH 8.0 (only 5% of all granules in the 
neural lobe remained dense cored at pH 8.0). In 
contrast, the granules in the perikarya in the SON 
and PVN showed a high degree of preservation of 
the dense core at pH 8.0 (7). The authors suggest 
that this difference in response to fixation at pH 
8.0 between hypothalamus and neural lobe may 
reflect "maturation" changes in the granule during 
axonal transport. This maturation presumably re- 
flects  the  precursor-to-product conversion  proc- 
ess. 
Diversity of Peptides Transported to 
the Posterior Pituitary 
The posterior pituitary gland is known to con- 
tain  a  wide variety of peptides relative to  other 
378  THE  JOURNAL  OF  CELL  BIOLOGY" VOLUME  73,  1977 tissues (46, 51). The biosynthesis-axonal  transport 
paradigm employed in this study has allowed us to 
examine which of these peptides were synthesized 
in the hypothalamus, i.e., the SON in our experi- 
ments, ultimately for release by the posterior pi- 
tuitary. Thus, by this approach, we have used two 
properties of the peptidergic neuron as "biological 
filters" to elucidate which peptides may be "func- 
tionally relevant": a) the axonal transport mecha- 
nism and b) the release mechanism at the nerve 
terminal. For the latter, the criterion of calcium- 
dependent release (12) was used. 
At  least  six  substantially labeled peptides,  in 
addition to  oxytocin  and  vasopressin, were  de- 
tected in the SON and the posterior pituitary, and 
were  released  by calcium-dependent, potassium 
depolarization  of  the  pituitary.  It  should  be 
pointed out that this represents a  minimum esti- 
mate  since only 35S-cysteine-containing peptides 
could be detected in these experiments. The use of 
other labeled amino acid precursors in future ex- 
periments may allow the resolution of still other 
peptides which are  synthesized in the  SON  and 
transported  to  the  neurohypophysis. The  func- 
tional significance of these  peptides,  other  than 
oxytocin  and  vasopressin,  is  unclear.  Whether 
they  are  simply degradative  by-products of  the 
post-translational cleavage of the precursor or are 
mediators of some still unknown hormonal func- 
tions (possibly trophic) of the posterior pituitary 
remains to be determined. 
Received  for  publication  30  September  1976,  and  in 
revised form 17 January  1977. 
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